Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours

Petra Haag, Ferdinand Frauscher, Johann Gradl, Alexander Seitz, Georg Schäfer, Jonathan Lindner, Alexander L. Klibanov, Georg Bartsch, Helmut Klocker, Iris E. Eder

    Research output: Contribution to journalArticle

    79 Citations (Scopus)

    Abstract

    We have shown recently that downregulation of the androgen receptor (AR), one of the key players in prostate tumor cells, with short antisense oligodeoxynucleotides (ODNs) results in inhibition of prostate tumor growth. Particularly with regard to an application of these antisense drugs in vivo, we now investigated the usefulness of microbubble-enhanced ultrasound to deliver these ODNs into prostate cancer cells. Our short antisense AR ODNs were loaded onto the lipid surface of cationic gas-filled microbubbles by ion charge binding, and delivered into the cells by bursting the loaded microbubbles with ultrasound. In vitro experiments were initially performed to show that this kind of delivery system works in principle. In fact, transfection of prostate tumor cells with antisense AR ODNs using microbubble-enhanced ultrasound resulted in 49% transfected cells, associated with a decrease in AR expression compared to untreated controls. In vivo, uptake of a digoxigenin-labelled ODN was found in prostate tumour xenografts in nude mice following intratumoral or intravenous injection of loaded microbubbles and subsequent exposure of the tumour to ultrasound, respectively. Our results show that ultrasound seems to be the driving force of this delivery system. Uptake of the ODN was also observed in tumors after treatment with ultrasound alone, with only minor differences compared to the combined use of microbubbles and ultrasound.

    Original languageEnglish (US)
    Pages (from-to)103-113
    Number of pages11
    JournalJournal of Steroid Biochemistry and Molecular Biology
    Volume102
    Issue number1-5 SPEC. ISS.
    DOIs
    StatePublished - Dec 2006

    Fingerprint

    Microbubbles
    Oligodeoxyribonucleotides
    Tumors
    Prostate
    Ultrasonics
    Androgen Receptors
    Neoplasms
    Cells
    Digoxigenin
    Heterografts
    Nude Mice
    Intravenous Injections
    Transfection
    human AR protein
    Prostatic Neoplasms
    Down-Regulation
    Gases
    Ions
    Lipids
    Growth

    Keywords

    • Androgen receptor
    • Antisense oligonucleotides
    • Microbubbles
    • Prostate cancer
    • Ultrasound

    ASJC Scopus subject areas

    • Biochemistry
    • Endocrinology

    Cite this

    Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. / Haag, Petra; Frauscher, Ferdinand; Gradl, Johann; Seitz, Alexander; Schäfer, Georg; Lindner, Jonathan; Klibanov, Alexander L.; Bartsch, Georg; Klocker, Helmut; Eder, Iris E.

    In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 102, No. 1-5 SPEC. ISS., 12.2006, p. 103-113.

    Research output: Contribution to journalArticle

    Haag, Petra ; Frauscher, Ferdinand ; Gradl, Johann ; Seitz, Alexander ; Schäfer, Georg ; Lindner, Jonathan ; Klibanov, Alexander L. ; Bartsch, Georg ; Klocker, Helmut ; Eder, Iris E. / Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. In: Journal of Steroid Biochemistry and Molecular Biology. 2006 ; Vol. 102, No. 1-5 SPEC. ISS. pp. 103-113.
    @article{f7ff045690214c5cbf6e44e509ea3d53,
    title = "Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours",
    abstract = "We have shown recently that downregulation of the androgen receptor (AR), one of the key players in prostate tumor cells, with short antisense oligodeoxynucleotides (ODNs) results in inhibition of prostate tumor growth. Particularly with regard to an application of these antisense drugs in vivo, we now investigated the usefulness of microbubble-enhanced ultrasound to deliver these ODNs into prostate cancer cells. Our short antisense AR ODNs were loaded onto the lipid surface of cationic gas-filled microbubbles by ion charge binding, and delivered into the cells by bursting the loaded microbubbles with ultrasound. In vitro experiments were initially performed to show that this kind of delivery system works in principle. In fact, transfection of prostate tumor cells with antisense AR ODNs using microbubble-enhanced ultrasound resulted in 49{\%} transfected cells, associated with a decrease in AR expression compared to untreated controls. In vivo, uptake of a digoxigenin-labelled ODN was found in prostate tumour xenografts in nude mice following intratumoral or intravenous injection of loaded microbubbles and subsequent exposure of the tumour to ultrasound, respectively. Our results show that ultrasound seems to be the driving force of this delivery system. Uptake of the ODN was also observed in tumors after treatment with ultrasound alone, with only minor differences compared to the combined use of microbubbles and ultrasound.",
    keywords = "Androgen receptor, Antisense oligonucleotides, Microbubbles, Prostate cancer, Ultrasound",
    author = "Petra Haag and Ferdinand Frauscher and Johann Gradl and Alexander Seitz and Georg Sch{\"a}fer and Jonathan Lindner and Klibanov, {Alexander L.} and Georg Bartsch and Helmut Klocker and Eder, {Iris E.}",
    year = "2006",
    month = "12",
    doi = "10.1016/j.jsbmb.2006.09.027",
    language = "English (US)",
    volume = "102",
    pages = "103--113",
    journal = "Journal of Steroid Biochemistry and Molecular Biology",
    issn = "0960-0760",
    publisher = "Elsevier Limited",
    number = "1-5 SPEC. ISS.",

    }

    TY - JOUR

    T1 - Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours

    AU - Haag, Petra

    AU - Frauscher, Ferdinand

    AU - Gradl, Johann

    AU - Seitz, Alexander

    AU - Schäfer, Georg

    AU - Lindner, Jonathan

    AU - Klibanov, Alexander L.

    AU - Bartsch, Georg

    AU - Klocker, Helmut

    AU - Eder, Iris E.

    PY - 2006/12

    Y1 - 2006/12

    N2 - We have shown recently that downregulation of the androgen receptor (AR), one of the key players in prostate tumor cells, with short antisense oligodeoxynucleotides (ODNs) results in inhibition of prostate tumor growth. Particularly with regard to an application of these antisense drugs in vivo, we now investigated the usefulness of microbubble-enhanced ultrasound to deliver these ODNs into prostate cancer cells. Our short antisense AR ODNs were loaded onto the lipid surface of cationic gas-filled microbubbles by ion charge binding, and delivered into the cells by bursting the loaded microbubbles with ultrasound. In vitro experiments were initially performed to show that this kind of delivery system works in principle. In fact, transfection of prostate tumor cells with antisense AR ODNs using microbubble-enhanced ultrasound resulted in 49% transfected cells, associated with a decrease in AR expression compared to untreated controls. In vivo, uptake of a digoxigenin-labelled ODN was found in prostate tumour xenografts in nude mice following intratumoral or intravenous injection of loaded microbubbles and subsequent exposure of the tumour to ultrasound, respectively. Our results show that ultrasound seems to be the driving force of this delivery system. Uptake of the ODN was also observed in tumors after treatment with ultrasound alone, with only minor differences compared to the combined use of microbubbles and ultrasound.

    AB - We have shown recently that downregulation of the androgen receptor (AR), one of the key players in prostate tumor cells, with short antisense oligodeoxynucleotides (ODNs) results in inhibition of prostate tumor growth. Particularly with regard to an application of these antisense drugs in vivo, we now investigated the usefulness of microbubble-enhanced ultrasound to deliver these ODNs into prostate cancer cells. Our short antisense AR ODNs were loaded onto the lipid surface of cationic gas-filled microbubbles by ion charge binding, and delivered into the cells by bursting the loaded microbubbles with ultrasound. In vitro experiments were initially performed to show that this kind of delivery system works in principle. In fact, transfection of prostate tumor cells with antisense AR ODNs using microbubble-enhanced ultrasound resulted in 49% transfected cells, associated with a decrease in AR expression compared to untreated controls. In vivo, uptake of a digoxigenin-labelled ODN was found in prostate tumour xenografts in nude mice following intratumoral or intravenous injection of loaded microbubbles and subsequent exposure of the tumour to ultrasound, respectively. Our results show that ultrasound seems to be the driving force of this delivery system. Uptake of the ODN was also observed in tumors after treatment with ultrasound alone, with only minor differences compared to the combined use of microbubbles and ultrasound.

    KW - Androgen receptor

    KW - Antisense oligonucleotides

    KW - Microbubbles

    KW - Prostate cancer

    KW - Ultrasound

    UR - http://www.scopus.com/inward/record.url?scp=33751001045&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33751001045&partnerID=8YFLogxK

    U2 - 10.1016/j.jsbmb.2006.09.027

    DO - 10.1016/j.jsbmb.2006.09.027

    M3 - Article

    VL - 102

    SP - 103

    EP - 113

    JO - Journal of Steroid Biochemistry and Molecular Biology

    JF - Journal of Steroid Biochemistry and Molecular Biology

    SN - 0960-0760

    IS - 1-5 SPEC. ISS.

    ER -